CA2371551A1 - Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives - Google Patents
Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives Download PDFInfo
- Publication number
- CA2371551A1 CA2371551A1 CA002371551A CA2371551A CA2371551A1 CA 2371551 A1 CA2371551 A1 CA 2371551A1 CA 002371551 A CA002371551 A CA 002371551A CA 2371551 A CA2371551 A CA 2371551A CA 2371551 A1 CA2371551 A1 CA 2371551A1
- Authority
- CA
- Canada
- Prior art keywords
- apc
- apocodeine
- derivatives
- adhesive
- male
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne trois compositions pharmaceutiques: timbres transdermiques à libération prolongée; pastilles à mâcher/sublinguales; aérosols à base d'apocodéine (APC) ou ses dérivés, pour le traitement de l'impuissance masculine et pour la stimulation de la libido chez les hommes et chez les femmes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE990389 | 1999-05-13 | ||
IE990389 | 1999-05-13 | ||
PCT/IE2000/000065 WO2000069416A1 (fr) | 1999-05-13 | 2000-05-12 | Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2371551A1 true CA2371551A1 (fr) | 2000-11-23 |
Family
ID=11042062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002371551A Abandoned CA2371551A1 (fr) | 1999-05-13 | 2000-05-12 | Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1175206A1 (fr) |
JP (1) | JP2002544221A (fr) |
AU (1) | AU4427000A (fr) |
CA (1) | CA2371551A1 (fr) |
MX (1) | MXPA01011480A (fr) |
NO (1) | NO20015519L (fr) |
WO (1) | WO2000069416A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001076602A1 (fr) * | 2000-04-07 | 2001-10-18 | Tap Pharmaceutical Products Inc. | Derives d'apomorphine et leurs procedes d'utilisation |
SE0002934D0 (sv) * | 2000-08-17 | 2000-08-17 | Axon Biochemicals Bv | New aporphine esters and in their use in therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
FI873428A (fi) * | 1986-08-18 | 1988-02-19 | Houston Biotechnology | Oftalmologiska kompositioner foer behandling av nervdegenerationer. |
DE69709646T2 (de) * | 1996-03-12 | 2002-08-14 | Alza Corp., Palo Alto | Zusammensetzung und dosisform mit einem opioid-antagonisten |
-
2000
- 2000-05-12 EP EP00925551A patent/EP1175206A1/fr not_active Withdrawn
- 2000-05-12 AU AU44270/00A patent/AU4427000A/en not_active Abandoned
- 2000-05-12 CA CA002371551A patent/CA2371551A1/fr not_active Abandoned
- 2000-05-12 MX MXPA01011480A patent/MXPA01011480A/es unknown
- 2000-05-12 JP JP2000617875A patent/JP2002544221A/ja active Pending
- 2000-05-12 WO PCT/IE2000/000065 patent/WO2000069416A1/fr not_active Application Discontinuation
-
2001
- 2001-11-12 NO NO20015519A patent/NO20015519L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20015519D0 (no) | 2001-11-12 |
WO2000069416A1 (fr) | 2000-11-23 |
EP1175206A1 (fr) | 2002-01-30 |
AU4427000A (en) | 2000-12-05 |
MXPA01011480A (es) | 2002-06-04 |
JP2002544221A (ja) | 2002-12-24 |
NO20015519L (no) | 2002-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI115034B (fi) | Menetelmä uudelleenkiteytymättömän estradiolia sisältävän laastarin valmistamiseksi | |
FI100693B (fi) | Menetelmä vaikuttavana aineena tulobuterolia sisältävän, ihon läpi vai kuttavan terapeuttisen järjestelmän valmistamiseksi | |
US20040202705A1 (en) | Transdermal administration of huperzine | |
WO2008021113A2 (fr) | Méthodes transdermiques et systèmes pour traiter la maladie d'alzheimer | |
WO2007120868A2 (fr) | Amélioration de la biodisponibilité d'un médicament lipophile à l'aide d'un système de solvants | |
US20120309823A1 (en) | Percutaneous absorption preparations | |
JP2540019B2 (ja) | 医薬組成物 | |
US20120077836A1 (en) | Methods of administering (4ar,10ar)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof | |
EP2650019B1 (fr) | Timbre transdermique contenant un antidépresseur noradrénergique et sérotoninergique spécifique | |
AU764025B2 (en) | Transdermal patch and topical compositions comprising propylnorapomorphine | |
US20080176913A1 (en) | Transdermal compositions of pramipexole having enhanced permeation properties | |
NO320050B1 (no) | Transmukosale formuleringer av levosimendan og anvendelse derav til fremstilling av faramasoytisk preparat. | |
CA2371551A1 (fr) | Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives | |
CN115475152A (zh) | 氟比洛芬的外用制剂及其制备方法 | |
CN112107561B (zh) | 含有壳聚糖的药物制剂、药物透皮贴剂及其制备方法 | |
JP6459148B2 (ja) | 経皮吸収型製剤 | |
Walters et al. | Dermal and Transdermal Drug Delivery Systems: An Overview and Recent Advancements | |
CN112057436A (zh) | 含有脂质的药物制剂、药物透皮贴剂及其制备方法 | |
JP3841628B2 (ja) | 経皮吸収剤 | |
WO2017057541A1 (fr) | Préparation d'absorption transdermique | |
JP2008231081A (ja) | ケトプロフェン含有外用剤 | |
Walters et al. | 1 Dermal Drug Delivery and Transdermal Systems | |
MXPA01000527A (en) | Transdermal patch and topical compositions comprising propylnorapomorphine | |
JP2017007994A (ja) | 経皮吸収型製剤 | |
AU2013206198A1 (en) | Methods of administering (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |